Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688687's 5-Year Yield-on-Cost % is ranked worse than 54.42% of 147
companies
in the Biotechnology industry
Industry Median: 1.64
vs SHSE:688687: 1.48
Beijing Kawin Technology Share-Holding Co (SHSE:688687) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Beijing Kawin Technology Share-Holding Co 5-Year Yield-on-Cost % Related Terms
SHSE:688687 vs VRTX, REGN, MRNA: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Beijing Kawin Technology Share-Holding Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Kawin Technology Share-Holding Co 5-Year Yield-on-Cost % vs Biotechnology Industry
Beijing Kawin Technology Share-Holding Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Beijing Kawin Technology Share-Holding Co (SHSE:688687) has a 5-Year Yield-on-Cost % of 1.48 as of Sep. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Beijing Kawin Technology Share-Holding Co and its competitors. This is 57% above median its historical median of 0.94. Over the past decade, Beijing Kawin Technology Share-Holding Co's 5-Year Yield-on-Cost % has ranged from 0.51 to 2.00. According to the industry distribution chart, Beijing Kawin Technology Share-Holding Co ranks #80 out of 147 companies in the Biotechnology industry, placing it in the top 54.4%.
Is Beijing Kawin Technology Share-Holding Co's 5-Year Yield-on-Cost % too high?
Beijing Kawin Technology Share-Holding Co's current 5-Year Yield-on-Cost % of 1.48 is 57% above median its 10-year median of 0.94. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 2.00. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.64. Beijing Kawin Technology Share-Holding Co's value of 1.48 is 9.8% below this industry median. Based on the distribution chart, Beijing Kawin Technology Share-Holding Co ranks #80 out of 147 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Beijing Kawin Technology Share-Holding Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Kawin Technology Share-Holding Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Kawin Technology Share-Holding Co ranks #80 out of 147 companies for 5-Year Yield-on-Cost %. This places Beijing Kawin Technology Share-Holding Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.64. Beijing Kawin Technology Share-Holding Co's value of 1.48 is 9.8% below this benchmark. Historically, Beijing Kawin Technology Share-Holding Co's own 5-Year Yield-on-Cost % has ranged from 0.51 to 2.00 over the past decade. While the company's 10-year median is 0.94 vs. the industry median of 1.64, Beijing Kawin Technology Share-Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.64, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Kawin Technology Share-Holding Co's current 5-Year Yield-on-Cost % of 1.48 is 9.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Beijing Kawin Technology Share-Holding Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Kawin Technology Share-Holding Co's current 5-Year Yield-on-Cost % is 1.48, which is 57% above median its own 10-year median of 0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Kawin Technology Share-Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Kawin Technology Share-Holding Co (SHSE:688687) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.14, compared to a current price of ¥16.98 — trading 26.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.48, which is 57% above median its 10-year median of 0.94 and 9.8% below the Biotechnology industry median of 1.64. Beijing Kawin Technology Share-Holding Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Beijing Kawin Technology Share-Holding Co (SHSE:688687), the current 5-Year Yield-on-Cost % is 1.48 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Kawin Technology Share-Holding Co (SHSE:688687) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Kawin Technology Share-Holding Co stock appears to be undervalued.
The current stock price of ¥16.98 is trading 26.6% below its estimated GF Value™ of ¥23.14.
GuruFocus considers Beijing Kawin Technology Share-Holding Co to be Modestly Undervalued.
Key valuation signals for SHSE:688687:
5-Year Yield-on-Cost %: 1.48 (57% above median its 10-year median of 0.94)
GF Value™: ¥23.14 vs. price of ¥16.98 (26.6% below fair value)
Industry Position: 9.8% below the Biotechnology median (#80 of 147)
No single metric tells the full story. See the SHSE:688687 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.
79GF Score
Get the complete analysis for SHSE:688687
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688687 has been successfully added to your 
